Clincosm LogoSign in Get a demo

Metastatic Melanoma

Showing 51 - 75 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Magnetic Resonance Imaging using 7 Tesla MRI
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Metastatic Melanoma Trial in Marseille (PET with 18F-FDOPA)

Completed
  • Metastatic Melanoma
  • PET with 18F-FDOPA
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Nov 9, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 8, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

Completed
Has Results
  • Metastatic Melanoma
  • +2 more
  • ADI PEG 20
  • New York, New York
  • +1 more
Oct 3, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

Recruiting
  • Malignant Digestive System Neoplasm
  • +12 more
  • Computed Tomography
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

Active, not recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • Birmingham, Alabama
  • +848 more
Aug 24, 2022

Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

Recruiting
  • Metastatic Melanoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +19 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 19, 2022

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in BRAF Mutated

Recruiting
  • Metastatic Melanoma
    • Montpellier, France
      Uhmontpellier
    Aug 19, 2022

    Solid Tumors, Metastatic Melanoma, NSCLC Trial in Worldwide (RO7247669)

    Recruiting
    • Solid Tumors
    • +3 more
    • San Diego, California
    • +20 more
    Aug 19, 2022

    Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

    Active, not recruiting
    • Metastatic Melanoma
    • +2 more
    • Aldesleukin
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Tumor, Metastatic Melanoma, Melanoma Trial in Houston (OBX-115, Acetazolamide, Cyclophosphamide)

    Not yet recruiting
    • Tumor
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 16, 2022

    Metastatic Melanoma Trial in Stockholm (Precision Radiation (SBRT))

    Recruiting
    • Metastatic Melanoma
    • Precision Radiation (SBRT)
    • Stockholm, Sweden
      Division of Head-Neck, Lung and Skin cancers, Theme Cancer, Karo
    Aug 16, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Metastatic Melanoma Trial (PV-001-DC)

    Not yet recruiting
    • Metastatic Melanoma
    • PV-001-DC
    • (no location specified)
    Aug 4, 2022

    AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

    Recruiting
    • AIDS-Related Non-Hodgkin Lymphoma
    • +29 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Birmingham, Alabama
    • +12 more
    Aug 4, 2022